Sirolimus therapy for fibromatosis and multifocal renal cell carcinoma in a child with tuberous sclerosis complex

Pediatric Blood and Cancer

Volumn 54, Issue 7, 2010, Pages 1035-1037

  Pressey, Joseph G ^a   Wright, Jordan M ^a   Geller, James I ^e   Joseph, David B ^b   Pressey, Christine S ^a   Kelly, David R ^c,d  

^a Heerskink School of Medicine   (United States)

^b Hugh Kaul Human Genetics Building   (United States)

^c CHILDREN S HOSPITAL OF ALABAMA   (United States)

^d University of Alabama at Birmingham   (United States)

^e CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

Cancer genetics; Developmental therapeutics; Pathology; Renal cell carcinoma; Soft tissue sarcoma

Indexed keywords

ARGININE; COLLAGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; CYTOKERATIN; GENOMIC DNA; GLUTAMINE; NUCLEOTIDE; RAPAMYCIN; TUMOR ANTIGEN; VIMENTIN;

ADIPOSE TISSUE; ALLELE; ANTIGEN EXPRESSION; ARTICLE; CANCER CHEMOTHERAPY; CANCER REGRESSION; CANCER SURGERY; CASE REPORT; CELL NUCLEUS; CELL PROLIFERATION; CHILD; CODON; CYTOPLASM; DNA EXTRACTION; DNA SEQUENCE; EOSINOPHIL; EXON; FIBROMATOSIS; GENE MUTATION; HETEROZYGOTE; HUMAN; KIDNEY CARCINOMA; KIDNEY PRESERVATION; MALE; MICROSCOPY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHOOL CHILD; SPINDLE CELL; THORAX SURGERY; THORAX WALL; TUBEROUS SCLEROSIS;

ANTIBIOTICS, ANTINEOPLASTIC; CARCINOMA, RENAL CELL; CHILD; FIBROMA; HUMANS; KIDNEY NEOPLASMS; LOSS OF HETEROZYGOSITY; MALE; SIROLIMUS; THORACIC WALL; TUBEROUS SCLEROSIS; TUMOR SUPPRESSOR PROTEINS;

EID: 77951749694     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.22401     Document Type: Article

References (20)

1. Crino PB, Nathanson KL, Henske EP. The tuberous sclerosis complex. N Engl J Med 2006;355:1345-1356.
2. Fleury RN, Damante JH, Soares CT, et al. Malignant fibrous histiocytoma (undifferentiated high-grade pleomorphic sarcoma) occurring in tuberous sclerosis: A case report. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007;103:e54-e59.
3. Armada RC, Longchong Ramos M, Marrero P, et al. Embryonal rhabdomyosarcoma associated with tuberous sclerosis. Med Pediatr Oncol 2002;38:302. (Pubitemid 34258435)
4. Inoki K, Corradetti MN, Guan KL. Dysregulation of the TSC-mTOR pathway in human disease. Nat Genet 2005;37:19-124. (Pubitemid 40070934)
5. Bissler JJ, McCormack FX, Young LR, et al. Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangio-leiomyomatosis. N Engl J Med 2008;358:140-151.
6. Franz DN, Leonard J, Tudor C, et al. Rapamycin causes regression of astrocytomas in tuberous sclerosis complex. Ann Neurol 2006;59:490-498. (Pubitemid 43358069)
7. Jones AC, Shyamsundar MM, Thomas MW, et al. Comprehensive mutation analysis of TSC1 and TSC2-and phenotypic correlations in 150 families with tuberous sclerosis. Am J Hum Genet 1999;64:1305-1315.
8. Choi JE, Chae JH, Hwang YS, et al. Mutational analysis of TSC1 and TSC2 in Korean patients with tuberous sclerosis complex. Brain Dev 2006;28:440-446. (Pubitemid 43914317)
9. Eisenhauer EA, Therasse P, Bogaerts J, et al. New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1). Eur J Cancer 2009;45:228-247.
10. Therasse P, Arbuck SG, Eisenhauer EA, et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 2000;92:205-216.
11. Washecka R, Hanna M. Malignant renal tumors in tuberous sclerosis. Urology 1991;37:340-343.
12. Breysem L, Nijs E, Proesmans W, et al. Tuberous sclerosis with cystic renal disease and multifocal renal cell carcinoma in a baby girl. Pediatr Radiol 2002;32:677-680. (Pubitemid 36067717)
13. Bjornsson J, Short MP, Kwiatkowski DJ, et al. Tuberous sclerosis-associated renal cell carcinoma. Clinical, pathological, and genetic features. Am J Pathol 1996;149:1201-1208. (Pubitemid 26337239)
14. Miyaki M, Konishi M, Kikuchi-Yanoshita R, et al. Coexistence of somatic and germ-line mutations of APC gene in desmoid tumors from patients with familial adenomatous polyposis. Cancer Res 1993;53:5079-5082. (Pubitemid 23333366)
15. Miyoshi Y, Iwao K, Nawa G, et al. Frequent mutations in the beta-catenin gene in desmoid tumors from patients without familial adenomatous polyposis. Oncol Res 1998;10:591-594. (Pubitemid 128740447)
16. Thway K, Gibson S, Ramsay A, et al. Beta-catenin expression in pediatric fibroblastic and myofibroblastic lesions: A study of 100 cases. Pediatr Dev Pathol 2009;12:292-296.
17. MiyamotoY, Satomura K, Rikimaru K, et al. Desmoplastic fibroma of the mandible associated with tuberous sclerosis. J Oral Pathol Med 1995;24:93-96.
18. Vargas-Gonzalez R, San Martin-Brieke W, Gil-Orduna C, et al. Desmoplastic fibroma-like tumor of maxillofacial region associated with tuberous sclerosis. Pathol Oncol Res 2004;10:237-239. (Pubitemid 40127703)
19. Houghton PJ, Morton CL, Kolb EA, et al. Initial testing (stage 1) of the mTOR inhibitor rapamycin by the pediatric preclinical testing program. Pediatr Blood Cancer 2008;50:799-805. (Pubitemid 351354788)
20. Fouladi M, Laningham F, Wu J, et al. Phase I study of everolimus in pediatric patients with refractory solid tumors. J Clin Oncol 2007;25:4806-4812. (Pubitemid 350086485)